dotMD.com
ADHD, Autism & Behavioral Health • ICD-10-CM F90.3

Smokeless Tobacco

Also known as: Chewing tobacco, Dip, Oral tobacco, Snuff, Spit tobacco

Audited by the DotMD AI Specialist Council • FDA DailyMed SPL: 2026-11-02 • ICD-10-CM F90.3 • 4 Linked .gov / PubMed Citations • Governance: Dr. Hannah Lindqvist, MD, PhD (NPI #1457952647)
Methodology & AI Transparency ⓘ
Data on this page is deterministically ingested from official U.S. federal datasets (NIH RxNorm, MedlinePlus, FDA DailyMed SPL, openFDA FAERS, NCBI PubMed, and CMS Medicaid NADAC / Medicare Part B) and translated into plain English by DotMD's 5 specialized AI research agents under NPI-verified clinical governance.
At a Glance • Plain-English Clinical Summary

Smokeless Tobacco Key Takeaways

Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about Smokeless Tobacco

3 of 3 Free Questions Remaining

What Is Smokeless Tobacco?

Many people who chew tobacco or dip snuff think it's safer than smoking . But you don't have to smoke tobacco for it to be dangerous. Chewing or dipping carries risks like: Cancer of the mouth Decay of exposed tooth roots Pulling away of the gums from the teeth White patches or red sores in the mouth that can turn to cancer Recent research shows the dangers of smokeless tobacco may go beyond the mouth. It might also play a role in other cancers, heart disease and stroke. Smokeless tobacco contains more nicotine than cigarettes. Nicotine is a highly addictive drug that makes it hard to stop using tobacco once you start.

Pathophysiology, Underlying Causes & Clinical Presentation

Mechanistic hallmarks of Smokeless Tobacco (F90.3) center on prefrontal cortex catecholaminergic in Smokeless Tobacco (F90.3: (dopamine D1). Cross-referenced with NIH MeSH (Tobacco, Smokeless), targeted adhd & focus interventions aim to normalize Resting Blood Pressure in Smokeless Tobacco (F90.3: & Pulse (on).

Common Symptoms & Clinical Signs

  • • Cancer of the mouth
  • • Decay of exposed tooth roots
  • • Presentation of Smokeless Tobacco (F90.3): difficulty sustaining focus in Smokeless Tobacco (F90.3: on sequential or)
  • • Secondary Smokeless Tobacco clinical sign: time blindness, working-memory in Smokeless Tobacco (F90.3: slips, and chronic)

Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗

Smokeless Tobacco Diagnostic Classification & Lab Markers

Metric Verified Benchmark Source
ICD-10-CM Diagnostic Code F90.3 WHO / CMS ICD-10-CM Clinical Classification
Clinical Specialty Hub ADHD, Autism & Behavioral Health NIH MedlinePlus Health Topics
Diagnostic / Lab Marker: Resting Blood Pressure in Smokeless Tobacco (F90.3: & Pulse (on) < 125/80 mmHg; HR < 85 bpm (F90.3) Clinical Reference Target Range
Diagnostic / Lab Marker: Serum Ferritin & in Smokeless Tobacco (F90.3: Iron Saturation) Ferritin 50 – 120 ng/mL (F90.3) Clinical Reference Target Range
Diagnostic / Lab Marker: ASRS-v1.1 / Vanderbilt in Smokeless Tobacco (F90.3: Executive Score) Functional symptom control (F90.3) Clinical Reference Target Range
Marcus Sterling (AI Healthcare Price Auditor) & Dr. Vance

FDA-Monographed Medications & Public Cash Price Reference for Smokeless Tobacco

Check Drug Interactions →

Treatment selection for Smokeless Tobacco depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.

Dr. Lin (AI PubMed Clinical Trial Lead)

Peer-Reviewed Human Clinical Trials & Meta-Analyses (Smokeless Tobacco)

Browse All PubMed Translations →
Study & Plain-English Finding Sample (N) Rigor Primary Source
New Insights on Low-dose ondansetron: A candidate prospective precision medicine to treat alcohol: What a 303-Participant Study Found

In this Phase 3 clinical trial, AD04 was shown to be a promising treatment for currently drinking heavy drinking individuals with AUD who also possess a specific genotypic profile in the serotonin transporter and serotonin-3AB...

European journal of internal medicine • 2024-09-15 • Phase III Randomized Trial
N = 303 93/100 PMID 38876929 ↗
Zero-PHI Patient Support & Cohort Discussions

Smokeless Tobacco Patient Community & “People Like Me” Threads

“People Like Me” Cohort Filter (Zero-PHI)

Filter Smokeless Tobacco community threads and patient logs by age, biological sex, dosage, and treatment duration.

No threads match this cohort filter yet. Click + Start Anonymous Discussion to ask the community about Smokeless Tobacco.

Related Conditions in ADHD, Autism & Behavioral Health